All included patient was submitted at baseline to a socio-demographic inventory and to a psychometric evaluation, the latter were reapplied at weeks 8 and 16. The psychometric evaluation consist of self-report instruments: CAPS to measure PTSD symptoms severity, the Beck Depression Inventory (BDI) [29] and the Beck Anxiety Inventory (BAI) [30] to measure the depressive and the anxiety symptoms severity, the Medical Outcome Scale short form (MOS-SF-36) [31] and the Social adjustment scale (SAS) [32] to evaluate quality of life and social adjustment. A 7.5mg single dose of aripiprazole was prescribed, and the patient was evaluated each two weeks and dose could be increased or decreased depending of their tolerability to side effects. After 16-week the drug was discontinued over a two week period.